THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Tough criticisms rise as biotech matures

Lawmakers point to high drug prices, crop worries

By Stephen Heuser
Globe Staff / May 8, 2007

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

Thirty years ago, the business of biotechnology amounted to a handful of scientists, a few brave investors, and a bold, if unproven, idea: By tweaking genes in a lab, you could transform the process of making drugs. (Full article: 1133 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass